Analyze Diet

Cross-protective immunity between equine encephalomyelitis viruses in equids.

Abstract: Eighteen equids were inoculated with eastern equine encephalomyelitis (EEE) and 18 equids with western equine encephalomyelitis (WEE) viruses to produce EEE virus- and WEE virus-immunized equids. Twelve surviving EEE virus-seropositive equids, 15 surviving WEE virus-seropositive equids, and 10 nonimmunized, seronegative equids (controls) were subsequently inoculated with an equine pathogenic (epizootic) strain of Venezuelan equine encephalomyelitis (VEE) virus to determine cross-protective immunity. Challenge infection produced 90% mortality in control (nonimmunized) equids, and 40% mortality in WEE virus-seropositive equids; all EEE virus-seropositive equids survived. Postchallenge exposure VEE viremia levels in EEE virus- or WEE virus-seropositive equids were lower than those in the 10 nonimmunized VEE virus-inoculated control equids. Plaque-neutralizing antibody responses to VEE virus in the EEE virus- and WEE virus-seropositive equids were similar in time of onset and titer to the antibody responses of nonimmunized equids. Neutralizing antibody to the third equine encephalomyelitis virus (either EEE virus or WEE virus) was detectable in 19 of 27 equids after inoculation with the challenge virus, VEE. Demonstration of cross-protective immunity between EEE or WEE virus and VEE virus in equids confirmed field observations made during the VEE epizootic in Texas in 1971.
Publication Date: 1989-09-01 PubMed ID: 2552875
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study examines the cross-protective immunity between different strains of horse encephalitis viruses in equids. It found that equids inoculated with eastern and western types demonstrated an immune response that lowered mortality rates when subsequently exposed to the Venezuelan variety.

Overview of Research Methods

  • Scientists inoculated a set of 18 equids each with eastern equine encephalomyelitis (EEE) and western equine encephalomyelitis (WEE) to create two separate groups of EEE and WEE virus-immunized equids.
  • Out of the surviving EEE and WEE virus-positive equids and a group of 10 non-immunized, seronegative equids (used as controls), each was subsequently exposed to an equine pathogenic strain of Venezuelan equine encephalomyelitis (VEE) virus.

Findings on Cross-Protective Immunity

  • From the process, the study found a high mortality rate of 90% among the control group of non-immunized equids.
  • In contrast, WEE virus-seropositive equids displayed a decrease in mortality at 40%, and all EEE virus-seropositive equids survived. This indicates an apparent cross-protective immunity in EEE and WEE virus-immunized equids against the VEE virus.
  • What’s more, post-challenge exposure of VEE viremia levels in EEE and WEE virus-seropositive equids were lower than those in the nonimmune control group, effectively demonstrating a distinct protection mechanism via a prior exposure to either EEE or WEE virus.
  • A significant similarity was also observed in the time of onset and titers of plaque-neutralizing antibody responses to VEE virus in both EEE and WEE virus-seropositive equids, compared to the responses in non-immunized equids.

Neutralizing Antibody to the Third Equine Encephalomyelitis Virus

  • The team detected neutralizing antibodies to the third equine encephalomyelitis virus (either EEE or WEE virus) in 19 of 27 equids after inoculation with the challenge virus. This shows that exposure to one type of equine encephalitis virus can stimulate an immune response against another strain.
  • These findings confirm field observations made during the VEE outbreak in Texas in 1971 and advance our understanding of interconnected immunity responses among different viruses in equids.

Cite This Article

APA
Walton TE, Jochim MM, Barber TL, Thompson LH. (1989). Cross-protective immunity between equine encephalomyelitis viruses in equids. Am J Vet Res, 50(9), 1442-1446.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 50
Issue: 9
Pages: 1442-1446

Researcher Affiliations

Walton, T E
  • USDA, Agricultural Research Service, Laramie, WY 82071-3965.
Jochim, M M
    Barber, T L
      Thompson, L H

        MeSH Terms

        • Alphavirus / immunology
        • Animals
        • Antibodies, Viral / analysis
        • Cross Reactions
        • Encephalitis Virus, Eastern Equine / immunology
        • Encephalitis Virus, Venezuelan Equine / immunology
        • Encephalitis Virus, Western Equine / immunology
        • Encephalomyelitis, Equine / immunology
        • Encephalomyelitis, Equine / veterinary
        • Encephalomyelitis, Venezuelan Equine / immunology
        • Encephalomyelitis, Venezuelan Equine / veterinary
        • Female
        • Horse Diseases / immunology
        • Horses
        • Immunity, Active
        • Immunization / veterinary
        • Male
        • Neutralization Tests
        • Species Specificity

        Citations

        This article has been cited 7 times.
        1. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective. Vaccines (Basel) 2022 Mar 4;10(3).
          doi: 10.3390/vaccines10030398pubmed: 35335029google scholar: lookup
        2. More S, Bøtner A, Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortázar Schmidt C, Michel V, Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Stegeman JA, Thulke HH, Velarde A, Willeberg P, Winckler C, Baldinelli F, Broglia A, Dhollander S, Beltrán-Beck B, Kohnle L, Morgado J, Bicout D. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): equine encephalomyelitis (Eastern and Western). EFSA J 2017 Jul;15(7):e04946.
          doi: 10.2903/j.efsa.2017.4946pubmed: 32625598google scholar: lookup
        3. Pauvolid-Corrêa A, Juliano RS, Campos Z, Velez J, Nogueira RM, Komar N. Neutralising antibodies for Mayaro virus in Pantanal, Brazil. Mem Inst Oswaldo Cruz 2015 Feb;110(1):125-33.
          doi: 10.1590/0074-02760140383pubmed: 25742272google scholar: lookup
        4. Zhang XS, Cao KF. The impact of coinfections and their simultaneous transmission on antigenic diversity and epidemic cycling of infectious diseases. Biomed Res Int 2014;2014:375862.
          doi: 10.1155/2014/375862pubmed: 25045666google scholar: lookup
        5. Chattopadhyay A, Wang E, Seymour R, Weaver SC, Rose JK. A chimeric vesiculo/alphavirus is an effective alphavirus vaccine. J Virol 2013 Jan;87(1):395-402.
          doi: 10.1128/JVI.01860-12pubmed: 23077320google scholar: lookup
        6. Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, Schroder WA, Higgs S, Suhrbier A. Chikungunya virus arthritis in adult wild-type mice. J Virol 2010 Aug;84(16):8021-32.
          doi: 10.1128/JVI.02603-09pubmed: 20519386google scholar: lookup
        7. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994 Jan;7(1):89-116.
          doi: 10.1128/CMR.7.1.89pubmed: 8118792google scholar: lookup